previous
show
intraperiton
infect
mous
hepat
viru
mhv
persist
interferong
ifng
defici
mice
result
subacut
fatal
periton
bear
resembl
felin
infecti
periton
examin
role
host
factor
mhv
infect
mice
ifngdefici
mice
balbc
background
balbgko
infect
intraperiton
mhv
compar
mice
contrast
mice
balbgko
mice
die
within
week
due
acut
hepat
failur
viral
titer
liver
balbgko
mice
significantli
higher
mice
hepatocyt
balbgko
mice
necrot
day
postinfect
clearli
distinct
larg
limit
lesion
liver
infect
mice
serum
alanin
aminotransferas
activ
infect
balbgko
mice
higher
mice
parallel
sever
patholog
chang
viral
titer
infect
mice
administr
exogen
ifng
balbgko
partial
inhibit
acut
death
result
indic
balbgko
mice
clearli
show
differ
diseas
follow
mhv
infect
although
wild
type
counterpart
mice
appar
show
clinic
cours
mhv
infect
murin
coronavirus
induc
varieti
diseas
includ
hepat
enter
enceph
mice
depend
viru
strain
infect
rout
age
genet
background
immun
statu
host
kyuwa
stohlman
compton
et
al
due
frequent
outbreak
murin
coronaviru
infect
laboratori
anim
facil
virus
detest
detriment
infecti
agent
laboratori
mice
hand
experiment
murin
coronaviru
infect
provid
use
anim
model
human
diseas
particular
murin
coronavirusinduc
demyelin
util
investig
pathogenesi
demyelin
diseas
multipl
sclerosi
human
liu
et
al
marten
et
al
wu
et
al
previous
report
reduc
viral
clearanc
result
system
persist
infect
associ
dissemin
granulomat
seros
ifngdefici
mice
intraperiton
ip
infect
murin
coronaviru
strain
jhm
jhmv
kyuwa
et
al
diseas
bear
resembl
felin
infecti
periton
anoth
coronavirusinduc
fatal
diseas
cat
diseas
also
observ
natur
infect
mice
defici
ifng
franc
et
al
well
ifng
doubl
knockout
mice
boivin
smith
experiment
infect
may
provid
uniqu
model
examin
patholog
mechan
virusinduc
periton
mention
genet
background
decis
factor
determin
fate
murin
coronaviru
infect
mice
exampl
wherea
sjlj
mice
resist
intracerebr
jhmv
infect
strain
laboratori
mice
suscept
stohlman
freling
recent
shown
viru
receptor
genotyp
correl
suscept
ohtsuka
taguchi
genet
profil
mous
suscept
anoth
murin
coronaviru
distinct
jhmv
levi
et
al
suggest
complex
suscept
murin
coronaviru
infect
vivo
see
role
mous
genet
background
murin
coronaviru
infect
ifngdefici
mice
attempt
experiment
ip
mhv
infect
ifngdefici
mice
balbc
background
balbgko
compar
mice
although
previou
studi
demonstr
wild
type
balbc
mice
suffer
acut
hepat
resolv
within
week
ip
infect
jhmv
similar
wild
type
mice
balbgko
mice
die
within
week
jhmv
infect
quit
differ
mice
product
mice
defici
ifng
describ
previous
tagawa
et
al
svj
mous
disrupt
ifng
gene
backcross
balbc
mice
eight
time
genotyp
mice
determin
pcr
describ
previous
tagawa
et
al
except
substitut
primer
instead
primer
femal
mice
use
breed
mice
maintain
laminar
flow
rack
environment
control
area
routin
check
ensur
serolog
free
murin
coronavirus
pathogen
agent
infect
mice
kept
safeti
cabinet
differ
area
experi
conduct
accord
institut
ethic
guidelin
anim
experi
safeti
guidelin
gene
manipul
experi
dl
variant
jhmv
propag
plaqu
assay
dbt
cell
describ
previous
kyuwa
et
al
singl
pool
viru
divid
aliquot
store
use
mice
infect
ip
pfu
jhmv
volum
ml
viral
isol
titrat
tissu
homogen
sampl
serial
dilut
plaqu
assay
dbt
cell
kyuwa
et
al
biochem
assess
liver
injuri
sera
jhmvinfect
mice
collect
fig
mortal
ifngdefici
balbc
mice
ip
jhmv
infect
twentyfour
homozyg
ten
heterozyg
ten
wildtyp
mice
homozyg
heterozyg
wildtyp
balbc
mice
ten
b
infect
ip
pfu
jhmv
monitor
day
buffer
formalin
embed
paraffin
section
stain
hematoxylin
eosin
recombin
murin
ifng
kindli
provid
shionogi
co
ltd
osaka
japan
balbgko
mice
n
infect
ip
pfu
jhmv
inject
u
ifng
h
day
infect
control
balbgko
mice
n
infect
ip
pfu
jhmv
inject
volum
phosphatebuff
salin
pb
evalu
statist
differ
data
obtain
mutant
control
mice
assess
statist
signific
student
ttest
differ
consid
statist
signific
pb
previou
studi
show
ip
infect
jhmv
induc
subacut
granulomat
seros
mice
kyuwa
et
al
see
whether
diseas
induc
ifngdefici
mice
genet
background
ifng
ifng
ifng
either
balbc
background
infect
ip
pfu
jhmv
observ
day
infect
wild
type
heterozyg
mice
surviv
appear
healthi
throughout
experi
fig
although
none
mice
die
first
week
surviv
rate
gradual
decreas
previous
describ
kyuwa
et
al
wild
type
heterozyg
balbc
mice
surviv
appear
healthi
throughout
experi
similar
mice
background
fig
howev
balbgko
mice
die
within
week
jhmv
infect
distinct
contrast
serum
alanin
aminotransferas
alt
activ
determin
enzymat
rate
method
commerci
kit
accord
manufactur
instruct
iatron
laboratori
tokyo
kyuwa
et
al
serum
collect
irradi
ultraviolet
ray
inactiv
jhmv
interferon
activ
determin
use
vesicular
stomat
viru
cell
flat
bottom
plate
inhibit
viral
cytopath
detect
naphthol
blueblack
stain
take
photometr
read
nm
tissu
sampl
fix
phosphat
understand
jhmv
infect
ifngdefici
mice
histopatholog
chang
liver
ifng
mice
either
balbc
background
compar
report
previous
kyuwa
et
al
jhmvinduc
lesion
day
postinfect
mice
larger
observ
heterozyg
counterpart
background
fig
b
hand
massiv
necrosi
observ
balbgko
mice
day
postinfect
fig
clearli
differ
focal
necrot
lesion
observ
mice
fig
liver
balbgko
mice
inflammatori
cell
rel
lymphoid
cell
scarc
infiltr
jhmvinfect
ifng
mice
balbc
background
focal
necrot
lesion
slightli
sever
observ
ifng
mice
background
fig
although
clear
differ
observ
ifng
ifng
mice
balbc
background
histopatholog
chang
liver
day
postinfect
obviou
day
postinfect
ifng
ifng
mice
show
focal
inflammatori
lesion
liver
fig
f
slight
rise
serum
atl
activ
observ
day
postinfect
ifng
ifng
mice
background
report
previous
tabl
concord
sever
histopatholog
chang
liver
balbgko
mice
remark
increas
alt
activ
observ
balbgko
mice
day
postinfect
jhmvinfect
ifng
balbc
mice
also
show
moder
increas
atl
activ
level
alt
activ
uninfect
mice
kul
sampl
collect
time
indic
n
data
express
mean
sd
balbc
sampl
collect
h
infect
n
data
express
mean
rel
high
level
ifn
activ
observ
ifngdefici
mice
well
balbc
background
h
postinfect
tabl
higher
level
ifn
activ
detect
heterozyg
mice
balbc
background
wherea
ifn
activ
heterozyg
mice
background
notic
low
confirm
ifng
detect
sampl
ifngdefici
mice
enzymelink
immunosorb
assay
data
shown
sinc
exogen
ifng
administr
partial
inhibit
jhmvinduc
subacut
fatal
diseas
mice
kyuwa
et
al
experi
conduct
use
jhmvinduc
acut
diseas
balbgko
mice
administr
recombin
ifng
clearli
increas
surviv
rate
balbgko
mice
follow
jhmv
infect
compar
treat
pb
fig
studi
demonstr
ip
infect
jhmv
induc
acut
death
ifngdefici
mice
balbc
background
high
serum
alt
activ
massiv
necrosi
liver
suggest
mice
die
due
acut
hepat
failur
diseas
ob
viral
titer
liver
mice
slightli
higher
heterozyg
mice
background
tabl
report
previous
kyuwa
et
al
essenti
phenomenon
observ
mice
balbc
background
viral
titer
balbgko
mice
higher
heterozyg
mice
day
postinfect
respect
howev
worth
note
valu
balbc
background
greater
background
exampl
viral
titer
balbgko
mice
day
postinfect
significantli
higher
mice
serv
heterozyg
wild
type
mice
background
administr
exogen
ifng
balbgko
mice
part
protect
virusinduc
acut
death
result
suggest
ifng
play
essenti
role
protect
mice
balbc
background
jhmv
infect
diseas
howev
notic
distinct
subacut
granulomat
periton
ifngdefici
mice
background
report
previous
kyuwa
et
al
wherea
hepat
observ
mice
acut
phase
progress
almost
cure
subacut
phase
granulomat
periton
evid
kyuwa
et
al
result
unexpect
wild
type
mice
genet
background
resist
ip
infect
jhmv
kyuwa
et
al
kyuwa
et
al
stohlman
et
al
strain
genotyp
mhv
receptor
believ
import
determin
mous
suscept
ohtsuka
taguchi
taken
togeth
data
present
suggest
genet
factor
ifng
mhv
receptor
affect
mhv
infect
mice
found
viral
titer
liver
balbgko
mice
significantli
higher
mice
sure
whether
critic
factor
determin
profil
mhv
infect
ifngdefici
mice
heterozyg
mice
balbc
background
also
rel
high
viral
burden
liver
although
viral
titer
mice
balbc
background
seem
somewhat
higher
background
remain
obscur
whether
differ
depend
upon
viral
replic
rate
hepatocyt
extrins
effect
immun
respons
interest
histopatholog
chang
liver
ifng
ifn
g
mice
balbc
background
drastic
diverg
day
postinfect
suggest
ifng
togeth
factor
would
play
role
prevent
expans
virusinduc
lesion
period
reconstitut
experi
could
protect
half
jhmvinfect
balbgko
mice
administr
ifng
h
day
infect
treat
ifng
period
exampl
day
postinfect
protect
complet
although
paper
report
infecti
diseas
cytokinedefici
balbc
mice
hu
et
al
kamradt
et
al
potter
et
al
paper
report
disrupt
singl
cytokin
gene
mice
gener
notabl
differ
consequ
among
mice
differ
genet
background
therefor
result
uniqu
experiment
model
may
provid
distinct
opportun
address
mechan
underli
protect
viral
infect
mammal
import
type
ifn
defens
viral
infect
demonstr
studi
mice
target
disrupt
infab
receptor
gene
ller
et
al
hwang
et
al
effect
type
ifn
protect
murin
coronaviru
infect
mice
also
report
uetsuka
et
al
matsuyama
et
al
present
studi
indic
serum
interferon
activ
jhmvinfect
balbgko
almost
result
suggest
type
ifn
key
factor
differ
profil
jhmv
infect
balbgko
fig
effect
ifng
treatment
jhmvinduc
acut
diseas
balbgko
mice
balbgko
mice
n
infect
ip
pfu
jhmv
inject
ip
u
recombin
murin
ifng
h
day
infect
control
balbgko
mice
n
infect
ip
pfu
inject
volum
pb
group
mice
monitor
day
postinfect
mice
interest
heterozyg
mice
balbc
background
also
show
high
level
serum
interferon
activ
may
play
role
concert
ifng
protect
mice
rel
high
viral
burden
liver
although
know
host
genet
factor
oper
differenti
balbgko
mice
induc
differ
form
diseas
two
mice
strain
show
disruptedgen
also
genet
factor
may
affect
phenotyp
genet
engin
mice
viru
infect
hand
report
geneknockout
mice
show
typic
phenotyp
due
compens
gene
function
gene
disrupt
doetschman
geneknockout
technolog
thu
offer
good
opportun
see
function
gene
vivo
sometim
show
us
exist
gene
involv
phenomenon
interest
